Who owns ELVN? 13F holders and whale ownership
ELVN is tracked across public portfolios in Whale Analyzer. This page answers who owns ELVN, which top funds are buying ELVN, aggregate disclosed value, and recent position changes based on public data. Samuel Isaly is the largest reported holder at $312M; the top five funds control 100.0% of reported ownership; institutions were net buying last quarter (1 increased, 0 reduced); the stock trades above the aggregate whale cost basis of $16.03. Top tracked holders include Samuel Isaly and Baker Bros. Advisors.
Continue to the live ELVN dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Samuel Isaly 13F portfolio OrbiMed Advisors holdings | $312.0M | 8.0M | Held |
| Baker Bros. Advisors 13F portfolio Baker Bros. Advisors holdings | $35.5M | 905.2K | Increased |
Ownership concentration
Reported ownership of ELVN is highly concentrated across tracked institutions.
- Single largest holder: 89.8% of reported ownership
- Top 5 holders: 100.0%
- Top 10 holders: 100.0%
Whale activity this quarter
Across 2 tracked institutions, 1 held, 1 increased. Net positioning is net buying.
- Samuel Isaly — OrbiMed Advisors ($312.0M) (→ 0.0% qoq shares) · avg cost $15.33
- Baker Bros. Advisors — Baker Bros. Advisors ($35.5M) (▲ 233.5% qoq shares) · avg cost $22.26
Whale cost basis vs current price
The aggregate tracked cost basis is $16.03 versus a current price of $50.08, so ELVN trades above its cost basis (+212.3%). Average unrealized P&L across tracked holders: 131%.
Sector positioning — Health Care
ELVN sits within the Health Care sector alongside 221 other tracked names. Compare whale ownership across peers:
How to use this page
Values are reported public positions from tracked 13F filers and disclosures — not real-time ownership totals. Open the live ELVN dashboard for price charts and cross-investor scans, or read the SEC 13F guide.
Related stock holder pages
- EWTX whale holders — EDGEWISE THERAPEUTICS INC
- LLY whale holders — ELI LILLY & CO
- SVA whale holders — SINOVAC BIOTECH LTD
- BSX whale holders — BOSTON SCIENTIFIC CORP
- SION whale holders — SIONNA THERAPEUTICS INC
- AZN whale holders — ASTRAZENECA PLC
- MYGN whale holders — MYRIAD GENETICS INC
- MBX whale holders — MBX BIOSCIENCES INC
Learn more in Whale Analyzer Academy
Deepen your read on ELVN with these Whale Analyzer Academy guides:
Frequently asked questions
Who owns ELVN stock?
Whale Analyzer tracks 2 public institutional holders of ELVN with a combined reported value of $347.5M. See the holder table above for the largest tracked positions.
Which top funds are buying ELVN?
Tracked institutions were net buying last quarter — 1 held, 1 increased. Check the "Change" column: "New" = fresh position, "Increased" = added, "Reduced" = trimmed.
How concentrated is ELVN ownership?
The top five tracked holders report 100.0% of aggregate ownership.
Is ELVN above or below the whale cost basis?
The aggregate tracked cost basis is $16.03 versus a current price of $50.08 (+212.3%).
What does 13F ownership mean for ELVN?
Use the interactive ELVN dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.